D.E. Shaw & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $175M | Buy |
1,367,792
+630,015
| +85% | +$78.6M | 0.14% | 220 |
|
|
2025
Q4 | $90M | Buy |
+737,777
| New | +$84.6M | 0.07% | 440 |
|
|
2025
Q3 | – | Sell |
-62,064
| Closed | -$5.15M | – | 5041 |
|
|
2025
Q2 | $5.15M | Sell |
62,064
-181,427
| -75% | -$14.5M | 0.01% | 2014 |
|
|
2025
Q1 | $19.7M | Sell |
243,491
-129,936
| -35% | -$11.6M | 0.02% | 953 |
|
|
2024
Q4 | $33.6M | Sell |
373,427
-629,378
| -63% | -$61M | 0.04% | 747 |
|
|
2024
Q3 | $99.1M | Buy |
+1,002,805
| New | +$98.5M | 0.13% | 272 |
|
|
2024
Q2 | – | Sell |
-303,111
| Closed | -$28.8M | – | 4939 |
|
|
2024
Q1 | $28.8M | Buy |
+303,111
| New | +$28.1M | 0.04% | 714 |
|
|
2023
Q2 | – | Sell |
-1,103,000
| Closed | -$84.1M | – | 4660 |
|
|
2023
Q1 | $84.1M | Sell |
1,103,000
-183,200
| -14% | -$15.2M | 0.14% | 262 |
|
|
2022
Q4 | $107M | Buy |
1,286,200
+771,200
| +150% | +$62.4M | 0.18% | 187 |
|
|
2022
Q3 | $40.9M | Buy |
+515,000
| New | +$43.4M | 0.07% | 479 |
|
|
2021
Q2 | – | Sell |
-14,700
| Closed | -$1.99M | – | 5113 |
|
|
2021
Q1 | $1.99M | Buy |
+14,700
| New | +$2.2M | ﹤0.01% | 2590 |
|
|
2020
Q2 | – | Sell |
-18,690
| Closed | -$1.45M | – | 4322 |
|
|
2020
Q1 | $1.45M | Sell |
18,690
-25,000
| -57% | -$2.21M | ﹤0.01% | 2437 |
|
|
2019
Q4 | $4.16M | Hold |
43,690
| – | – | 0.01% | 1869 |
|
|
2019
Q3 | $3.33M | Buy |
+43,690
| New | +$3.63M | 0.01% | 1964 |
|
|
2017
Q1 | – | Sell |
-10,000
| Closed | -$592K | – | 3698 |
|
|
2016
Q4 | $592K | Buy |
+10,000
| New | +$617K | ﹤0.01% | 2753 |
|
|
2016
Q3 | – | Sell |
-47,700
| Closed | -$2.58M | – | 3605 |
|
|
2016
Q2 | $2.58M | Buy |
+47,700
| New | +$2.61M | 0.01% | 1742 |
|
Other funds holding XBI
